医学
哮喘
流行病学
哮喘管理
家庭医学
医疗保健
公共卫生
地球仪
梅德林
循证医学
重症监护医学
替代医学
病理
经济增长
法学
内科学
经济
眼科
政治学
作者
Ritesh Agarwal,Sahajal Dhooria,Ashutosh N. Aggarwal,Venkata Nagarjuna Maturu,Inderpaul Singh Sehgal,Valliappan Muthu,Kuruswamy Thurai Prasad,Lakshmikant B Yenge,Navneet Singh,Digambar Behera,Surinder K. Jindal,Dheeraj Gupta,T Balamugesh,Ashish Bhalla,Dhruva Chaudhry,Sunil K. Chhabra,Ramesh Chokhani,Vishal Chopra,Devendra Singh Dadhwal,George D’Souza
出处
期刊:PubMed
[National Institutes of Health]
日期:2015-01-01
卷期号:57 Spec No: 5-52
被引量:4
摘要
Bronchial asthma is an important public health problem in India with significant morbidity. Several international guidelines for diagnosis and management of asthma are available, however there is a need for country-specific guidelines due to vast differences in availability and affordability of health-care facilities across the globe. The Indian Chest Society (ICS) and the National College of Chest Physicians (NCCP) of India have collaborated to develop evidence-based guidelines with an aim to assist physicians at all levels of health-care in diagnosis and management of asthma in a scientific manner. Besides a systematic review of the literature, Indian studies were specifically analysed to arrive at simple and practical recommendations. The evidence is presented under these five headings: (1) definitions, epidemiology and impact, (2) diagnosis, (3) pharmacologic management of stable disease, (4) management of acute exacerbations, and (5) non-pharmacologic management and special situations. The modified grade system was used for classifying the quality of evidence as 1, 2, 3, or usual practice point (UPP). The strength of recommendation was graded as A or B depending upon the level of evidence.
科研通智能强力驱动
Strongly Powered by AbleSci AI